Teleflex to focus on showcasing its Emergency Medicine portfolio at ERC 2015 - European Resuscitation Council, October 29 to ...
October 28 2015 - 5:45AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies for critical care and surgery, is committed to
connecting clinicians with technology in a way that improves
clinical practice and advances patient outcomes. Teleflex will
showcase its broad portfolio of products for the field of emergency
medicine at the ERC European Resuscitation Council, to be held in
Prague, Czech Republic on October 29-31, 2015.
During the event, Teleflex will highlight its range of
innovative solutions for intraosseous vascular access, rescue
airway, atomization and intubation needs. This includes the Arrow®
EZ-IO® Intraosseous Vascular Access System, the LMA Supreme®
Airway, as well as the LMA® MAD Nasal™ Intranasal Mucosal
Atomization Device. Teleflex will also be hosting several in-booth
scenario workshops.
The Arrow® EZ-IO® Intraosseous Vascular Access System from
Teleflex is a complete solution for rapid vascular access – whether
the emergency responder is facing difficult vascular access
challenges or the need for fast intraosseous access for critical
situations and life-threatening emergencies. This system is
designed to provide the medical professional vascular access to the
central circulation system within seconds1, delivering medications,
intravenous fluids and blood products to adult and pediatric
patients alike.
The LMA Supreme® Airway is a laryngeal mask offering a safe and
effective option for establishing an emergency airway. Featuring a
built-in drain tube to channel gastric secretions away from the
airway, the LMA Supreme® Airway is an ideal choice for patients
undergoing certain procedures requiring mechanical ventilation in
the field.
Another featured product will be the LMA® MAD Nasal™ Intranasal
Mucosal Atomization Device from Teleflex. When IV drug delivery is
less than ideal the LMA® MAD Nasal™ Device2 can come to the rescue
delivering safe, painless and rapidly effective treatment. No
needle. No trauma. No risk of needle stick injury.
The Teleflex Clinical & Medical Affairs team will be on hand
to conduct scenario based resuscitation scenarios on high fidelity
simulation models. The team of highly experienced clinicians from
across Europe and the United States will lead scenarios focusing on
providing the latest, evidence based interventions related to
intraosseous needle placement, intranasal medication delivery,
supraglottic airway placement, direct as well as video
laryngoscopy. These interactive sessions will help educate
clinicians from around Europe, advancing clinical practice and
improving patient outcomes.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, EZ-IO, Hudson RCI,
LMA, LMA Supreme, MAD Nasal, Pilling, and Weck are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates,
in the U.S. and/or other countries. © 2015 Teleflex Incorporated.
All rights reserved.
References:
1. Von Hoff DD , Kuhn JG, Burris HA, Miller LJ. Does
intraosseous equal intravenous? A pharmacokinetic study. Amer J
Emerg Med 2008;26:31-8
2. For use with drugs approved for intranasal delivery
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151028005047/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836orMartina Teichmann-ZindlerDirector
Marketing Communications International+49
(0)7151-406-538martina.teichmann@teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2024 to May 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From May 2023 to May 2024